Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (217)

Published on in Vol 5, No 3 (2016): Jul-Sept

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Preventing Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome in High-Risk Patients: Protocol of a Randomized Placebo-Controlled Trial of Prednisone (PredART Trial)

Authors of this article:

Cari Stek1, 2, 3 Author Orcid Image ;   Charlotte Schutz1, 3 Author Orcid Image ;   Lisette Blumenthal1, 3 Author Orcid Image ;   Friedrich Thienemann1, 3 Author Orcid Image ;   Jozefien Buyze2 Author Orcid Image ;   Christiana Nöstlinger4 Author Orcid Image ;   Raffaella Ravinetto2 Author Orcid Image ;   Edwin Wouters5 Author Orcid Image ;   Robert Colebunders2 Author Orcid Image ;   Gary Maartens3 Author Orcid Image ;   Robert J Wilkinson1, 3, 6, 7 Author Orcid Image ;   Lutgarde Lynen2 Author Orcid Image ;   Graeme Meintjes1, 3 Author Orcid Image
Article Authors Cited by (11) Tweetations (1) Metrics

Altmetric

Altmetric discovers Social Media mentions. Click the ‘See more details’ link for a full report.

Dimensions

Dimensions discovers Citations. Click the ‘details’ link for a full report.

Metrics Since Publication

Download .csv
Daily | Monthly | Annually